Sao Paulo, Brazil: The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, controls sleep disorders in patients with Parkinson’s disease (PD),…
Browsing: Medicinal
A new study e-published ahead of print by Neuropsychopharmacology, the official publication of the American College of Neuropsychopharmacology, has determined…
Maintaining “robust” encendocannabinoid signaling – which can be done through through the intake of cannabinoids – may provide protection against…
A study published in last month’s issue of the journal Schizophrenia Research has found that cannabis use, regardless of how…
SASKATOON, May 22, 2014 – Prairie Plant Systems Inc., parent company of CanniMed Ltd., announced today that Health Canada has…
A new study published in this month’s issue of the journal Kidney International, and published online by the U.S. National…
